Florida researchers noticed that people with cancer tended not to get Alzheimer’s disease. So, FDA approved anti-cancer drugs were screened to see how well they
The BBB (blood-brain barrier) has long blocked many oral drugs from getting to the brain. Nose-to-brain delivery of Alzheimer’s drugs is a breakthrough technique that
VIDEO & ARTICLE: Alzheimer’s starts doing damage years before anyone notices any signs. Many doctors believe that if we could only catch it early enough,
Can an implantable neural device stimulate brain cells to help restore memory? Find out why the U.S. Department of Defense is betting millions that it
Roche’s “Brain Shuttle” technology is helping antibodies fight Alzheimer’s. The body’s “Blood-Brain Barrier” blocks antibodies from getting to an Alzheimer’s brain. Learn how the Roche
VIDEO: Interested in Alzheimer’s research? Then don’t miss these Alzheimer’s Disease Progress Report highlights. See why the NIH is America’s center of dementia research.
Researchers discovered how genetic mutations in Huntington’s disease kill brain cells. Learn why this discovery may be relevant to other types of dementia, as well.
The Alzheimer’s drugs on the market today help compensate for the problems caused by Alzheimer’s. However, they do not stop the disease or change its
The off-label use of current antipsychotic medications for dementia is linked to increased mortality, serious adverse events, and cognitive decline. Learn how the pimavanserin trial
Penn State’s Professor Chen has developed an innovative model of regenerating neurons in Alzheimer’s. Learn how Dr. Chen hopes to develop this further in the
VIDEO + ARTICLE: Residential areas with more green space were associated with faster thinking, better attention, and higher overall cognitive function in a federal study. Learn more.
Lecanemab is today’s #1 Alzheimer’s antibody. (Brand name: Leqembi) Washington University researchers found Lecanemab’s adverse events to be rare and manageable in very mild or mild Alzheimer’s.
Alzheimer’s is characterized by an overproduction of free radicals in cells. That’s why incredibly tiny “nanoparticles” of silver, found in supplements, cosmetics and food packaging, worry scientists. Hear their concerns, as well as products to avoid.
SHORT-TERM MEMORY lapses are obvious signs of Alzheimer’s, but other tell-tale signals begin to show much earlier. Learn how to look for semantic impairments, such as simple questions about size.
Three important dementia studies focus on HS-AGING, a type of dementia almost as common as Alzheimer’s in the 85+ group. Yet few people have heard of it. Why? What makes it different?
An intriguing study of 120 grandmothers might surprise you. Doctors know socially engaged people have better cognition and less dementia. But can a person get too much of a good thing? What’s the right balance?
Enjoy this great duet between a musician with dementia and his son. A triumph of spirit over Alzheimer’s! Sing-a-long if you like!
No spam, only news and updates.
